Literature DB >> 33644787

Recent progress in non-native nucleic acid modifications.

Luke K McKenzie1, Roberto El-Khoury2, James D Thorpe2, Masad J Damha2, Marcel Hollenstein1.   

Abstract

While Nature harnesses RNA and DNA to store, read and write genetic information, the inherent programmability, synthetic accessibility and wide functionality of these nucleic acids make them attractive tools for use in a vast array of applications. In medicine, antisense oligonucleotides (ASOs), siRNAs, and therapeutic aptamers are explored as potent targeted treatment and diagnostic modalities, while in the technological field oligonucleotides have found use in new materials, catalysis, and data storage. The use of natural oligonucleotides limits the possible chemical functionality of resulting technologies while inherent shortcomings, such as susceptibility to nuclease degradation, provide obstacles to their application. Modified oligonucleotides, at the level of the nucleobase, sugar and/or phosphate backbone, are widely used to overcome these limitations. This review provides the reader with an overview of non-native modifications and the challenges faced in the design, synthesis, application and outlook of novel modified oligonucleotides.

Entities:  

Year:  2021        PMID: 33644787     DOI: 10.1039/d0cs01430c

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  20 in total

1.  Programmable manipulation of oligonucleotide-albumin interaction for elongated circulation time.

Authors:  Cai Yang; Haitao Zhao; Yang Sun; Cheng Wang; Xinyao Geng; Ruowen Wang; Lumin Tang; Da Han; Jianjun Liu; Weihong Tan
Journal:  Nucleic Acids Res       Date:  2022-04-08       Impact factor: 16.971

2.  A modular XNAzyme cleaves long, structured RNAs under physiological conditions and enables allele-specific gene silencing.

Authors:  Alexander I Taylor; Christopher J K Wan; Maria J Donde; Sew-Yeu Peak-Chew; Philipp Holliger
Journal:  Nat Chem       Date:  2022-09-05       Impact factor: 24.274

Review 3.  Combating small molecule environmental contaminants: detection and sequestration using functional nucleic acids.

Authors:  Aimee A Sanford; Brea A Manuel; Misael A Romero-Reyes; Jennifer M Heemstra
Journal:  Chem Sci       Date:  2022-06-06       Impact factor: 9.969

Review 4.  The multifaceted roles of mass spectrometric analysis in nucleic acids drug discovery and development.

Authors:  Thomas Kenderdine; Dan Fabris
Journal:  Mass Spectrom Rev       Date:  2021-12-23       Impact factor: 9.011

Review 5.  Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents.

Authors:  Samira Husen Alamudi; Michiko Kimoto; Ichiro Hirao
Journal:  RSC Med Chem       Date:  2021-07-24

Review 6.  Drug delivery systems for RNA therapeutics.

Authors:  Kalina Paunovska; David Loughrey; James E Dahlman
Journal:  Nat Rev Genet       Date:  2022-01-04       Impact factor: 59.581

7.  A ruthenium-oligonucleotide bioconjugated photosensitizing aptamer for cancer cell specific photodynamic therapy.

Authors:  Luke K McKenzie; Marie Flamme; Patrick S Felder; Johannes Karges; Frederic Bonhomme; Albert Gandioso; Christian Malosse; Gilles Gasser; Marcel Hollenstein
Journal:  RSC Chem Biol       Date:  2021-11-02

Review 8.  Convertible and Constrained Nucleotides: The 2'-Deoxyribose 5'-C-Functionalization Approach, a French Touch.

Authors:  Crystalle Chardet; Corinne Payrastre; Béatrice Gerland; Jean-Marc Escudier
Journal:  Molecules       Date:  2021-09-30       Impact factor: 4.411

9.  Therapeutic reversal of Huntington's disease by in vivo self-assembled siRNAs.

Authors:  Li Zhang; Tengteng Wu; Yangyang Shan; Ge Li; Xue Ni; Xiaorui Chen; Xiuting Hu; Lishan Lin; Yongchao Li; Yalun Guan; Jinfeng Gao; Dingbang Chen; Yu Zhang; Zhong Pei; Xi Chen
Journal:  Brain       Date:  2021-12-16       Impact factor: 13.501

Review 10.  Advances in Therapeutic L-Nucleosides and L-Nucleic Acids with Unusual Handedness.

Authors:  Yuliya Dantsu; Ying Zhang; Wen Zhang
Journal:  Genes (Basel)       Date:  2021-12-24       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.